Skip to content

Evaluation of the effectiveness of Iralvex gel on the recurrent aphthous ulcer healing

Evaluation of the effectiveness of Iralvex gel on the recurrent aphthous ulcer healing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201207253251N3
Enrollment
40
Registered
2012-07-31
Start date
2012-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent oral aphthous ulcers. Recurrent oral aphthae

Interventions

Intervention 1: Iralvex gel made by GOL DARU Co in Isfahan . According to the manufacturer's instructions: At least three times a day put one centimeter of gel on the wound place. Also, Patients are a
Treatment - Drugs
Placebo
Iralvex gel made by GOL DARU Co in Isfahan . According to the manufacturer's instructions: At least three times a day put one centimeter of gel on the wound place. Also, Patients are asked to avoid ea
Placebo gel made by GOL DARU Co in Isfahan . According to the manufacturer's instructions for Iralvex gel: The patients should put one centimeter of gel on the wound at least three times a day. Also,

Sponsors

Research vice chancellor of Isfahan Dental School- Isfahan University of Medical Sciences.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient's satisfaction of participating in the study; Positive history of minor aphthous ulcer and prove the existence of aphthous by physical examination; Patient should be non-smoker and have no systemic disease and immune deficiencies; Patients should not use any herbal or synthetic form of topical and systemic drug. Exclusion criteria: The patient wants to withdraw from the study; Occur of adverse drug in a patient

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Time of complete remission of lesions. Timepoint: When the patient feels complete remission. Method of measurement: Questionnaire and examination.;Duration of pain loss. Timepoint: When the patient feels no pain. Method of measurement: Questionnaire.;The intensity of pain. Timepoint: Before the intervention, the first day after the intervention, the third day after the intervention, the fifth days after intervention. Method of measurement: VAS Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Tavangar

Oral Medicine Department

tavangar@dnt.mui.ac.ir+98 31 1792 2814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 7, 2026